Answer
Vimkunya is thought to induce neutralising antibodies against chikungunya virus proteins C, E1 and E2, neutralising live virus, with an adjuvant enhancing immune responses, although its exact protective mechanism has not been determined.
Sources for this answer
- VIMKUNYA suspension for injection in pre-filled syringeBavarian Nordic UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked